NCT06077214View on ClinicalTrials.gov

Liposomal Bupivacaine for Post-operative Pain Control in Adolescent Bariatric Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2023

Primary Completion Date

August 20, 2024

Study Completion Date

August 20, 2024

Conditions
Bariatric Surgery CandidatePost-operative Pain
Interventions
DRUG

Treatment with liposomal bupivacaine

Patients will randomly be treated with either liposomal bupivacaine (study drug) after undergoing bariatric surgery.

DRUG

Treatment with standard bupivacaine

Patients will randomly be treated with standard bupivacaine after undergoing bariatric surgery.

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER